Jon Oxley

6.7k total citations
54 papers, 1.1k citations indexed

About

Jon Oxley is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jon Oxley has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 11 papers in Oncology. Recurrent topics in Jon Oxley's work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Urologic and reproductive health conditions (10 papers). Jon Oxley is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Urologic and reproductive health conditions (10 papers). Jon Oxley collaborates with scholars based in United Kingdom, Canada and Germany. Jon Oxley's co-authors include David Gillatt, Raj Persad, Jessica Charlet, Jennifer Batson, Shereen Kadir, Jonathan W. Astin, Catherine D. Nobes, Marialena Trivella, Sebastian Oltean and Michael Ladomery and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Oncogene.

In The Last Decade

Jon Oxley

53 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jon Oxley 395 384 226 171 157 54 1.1k
S. Bruce Malkowicz 349 0.9× 381 1.0× 264 1.2× 135 0.8× 115 0.7× 59 1.2k
Mark Feneley 525 1.3× 293 0.8× 380 1.7× 125 0.7× 106 0.7× 65 1.3k
Yukie Takimoto 465 1.2× 235 0.6× 92 0.4× 143 0.8× 131 0.8× 29 785
Virgil Gadaleanu 274 0.7× 312 0.8× 132 0.6× 164 1.0× 125 0.8× 24 828
J. Fenimore Cooper 323 0.8× 668 1.7× 232 1.0× 150 0.9× 99 0.6× 38 1.4k
Kristin Delfino 165 0.4× 248 0.6× 137 0.6× 109 0.6× 137 0.9× 62 834
Joshua I. Warrick 278 0.7× 592 1.5× 600 2.7× 239 1.4× 240 1.5× 72 1.6k
Ying-hao SUN 217 0.5× 335 0.9× 304 1.3× 103 0.6× 191 1.2× 87 1.0k
E. Dreher 67 0.2× 302 0.8× 313 1.4× 213 1.2× 46 0.3× 63 1.2k
S. Langbein 117 0.3× 448 1.2× 231 1.0× 101 0.6× 285 1.8× 37 925

Countries citing papers authored by Jon Oxley

Since Specialization
Citations

This map shows the geographic impact of Jon Oxley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Oxley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Oxley more than expected).

Fields of papers citing papers by Jon Oxley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Oxley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Oxley. The network helps show where Jon Oxley may publish in the future.

Co-authorship network of co-authors of Jon Oxley

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Oxley. A scholar is included among the top collaborators of Jon Oxley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Oxley. Jon Oxley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Downes, Michelle R., Katherine Lajkosz, Ferrán Algaba, et al.. (2025). Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study. Histopathology. 87(5). 649–659. 2 indexed citations
2.
Oxley, Jon, et al.. (2024). A Rare Case of Urinary Bladder Leiomyoma Invading Urachal Remnant Managed With Robotic Partial Cystectomy. Cureus. 16(7). e64222–e64222. 1 indexed citations
3.
4.
Challapalli, Amarnath, Paul White, S.K. Pearson, et al.. (2021). A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder. Clinical Genitourinary Cancer. 19(4). 325–332. 4 indexed citations
5.
Biernacka, Kalina, Rachel Barker, Hanna Zielińska, et al.. (2021). Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers. 13(4). 825–825. 6 indexed citations
6.
Oxley, Jon, et al.. (2020). Errors in prostate core biopsy diagnosis in an era of specialisation and double reporting. Journal of Clinical Pathology. 74(5). 327–330. 2 indexed citations
7.
Prendeville, Susan, Daniel M. Berney, Lukas Bubendorf, et al.. (2019). Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology. Histopathology. 74(6). 844–852. 5 indexed citations
8.
Penfold, Chris, Claire M. Perks, Jeff M.P. Holly, et al.. (2019). Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer. BMJ Open. 9(11). e029480–e029480. 10 indexed citations
9.
Kench, James G., Meagan Judge, Brett Delahunt, et al.. (2019). Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(3). 263–277. 19 indexed citations
10.
Thurairaja, Ramesh, et al.. (2014). Pathological analysis of lymph nodes in anterior prostatic fat excised at robot-assisted radical prostatectomy. Journal of Clinical Pathology. 67(9). 787–791. 10 indexed citations
11.
Warren, Katherine, Jon Oxley, & Anthony Koupparis. (2014). Pure malignant rhabdoid tumour of the bladder. Canadian Urological Association Journal. 8(3-4). 260–260. 8 indexed citations
12.
Mavrou, A, Karen Brakspear, Maryam Hamdollah‐Zadeh, et al.. (2014). Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene. 34(33). 4311–4319. 121 indexed citations
13.
Simpkin, Andrew J., et al.. (2013). What is the point of tips?. Journal of Clinical Pathology. 67(1). 40–44. 1 indexed citations
14.
Baker, Simon C., Jens Stahlschmidt, Jon Oxley, et al.. (2013). Nerve hyperplasia: a unique feature of ketamine cystitis. Acta Neuropathologica Communications. 1(1). 64–64. 29 indexed citations
15.
Oxley, Jon, et al.. (2012). Primary High-grade Serous Carcinoma Arising in the Urethra or Urethral Diverticulum. International Journal of Gynecological Pathology. 32(1). 141–145. 8 indexed citations
16.
Astin, Jonathan W., Jennifer Batson, Shereen Kadir, et al.. (2010). Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nature Cell Biology. 12(12). 1194–1204. 201 indexed citations
17.
Connolly, Maureen, Sunil K. Narayan, Jon Oxley, & D. A. R. de Berker. (2008). Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma. Clinical and Experimental Dermatology. 33(5). 625–628. 29 indexed citations
18.
Cottrell, Angela M., et al.. (2008). Suspected penile cancer: a method to improve handling of pathology specimens. British Journal of Urology. 101(10). 1325–1328. 2 indexed citations
19.
Oxley, Jon, Jeremy A. Sullivan, Andrew Mitchelmore, & David Gillatt. (2007). Metastatic renal oncocytoma. Journal of Clinical Pathology. 60(6). 720–722. 35 indexed citations
20.
Robinson, Max, Jon Oxley, Justin Weir, & J.W. Eveson. (2006). Lichenoid and granulomatous stomatitis: an entity or a non‐specific inflammatory process?. Journal of Oral Pathology and Medicine. 35(5). 262–267. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026